Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biocon, Bio-Thera, Daiichi, GC Biopharma.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Medtronic, Seimens, Spirair, Takeda.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ARS, Imcheck, Knight, Novartis.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aldeyra, Astrazeneca, Daiichi, GC Biopharma, GSK, J&J, Praxis, Rocket.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arthrex, Piccolo, Rivanna, Tasso.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amphix, Biocon, Bio-Thera, Endeavor, Genascence, Kalvista, Kezar, Sanofi.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Tempus AI.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alzecure, Shorla.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Caranx, Medtronic, Wenzel Spine.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Atara, Bayer, Biodexa, Corcept, GSK, Nanoscope,Ultragenyx, Valneva, Zenith.